FutuurCheck availabilityVerified resolution dataCurrent implied probability
3-5 52.5%Leader of 4 outcomes
3-5 52.5%Market quality
32 / 100
Low quality24h Volume
—
Liquidity
$1.1K
Low liquidityTraders
17
Comments
0
Market data
Updated 1 minute ago
Trends
Rules
This event predicts the total number of distinct interventional human clinical trials that have started in Prospera as of 11:59 PM CST on December 31, 2026.
- The Primary Designated Source (PDS) will be the Prospera Business Registration Report, used together with public clinical-trial registry records (ClinicalTrials.gov or a WHO primary registry) to identify qualifying trials.
- If the total number of distinct interventional human clinical trials meeting all criteria (interventional in humans; Study Start Date on or before Dec 31, 2026; and a registry record that either (i) explicitly lists a study location in Próspera/Prospera/Prospera ZEDE, or (ii) lists Roatán, Honduras and is corroborated by an authoritative source stating the site is in Prospera) falls within the value range defined for tone of the listed markets, that market will resolve to "Yes".
- All other markets will resolve to "No".
- Observational studies do not count, and each distinct registry identifier counts once.
- If registry location is unclear, corroboration may use sponsor pages/press releases, Prospera official gazette/registry pages, or reputable news/trade publications.
